6679. Becevit tablets.    (F.D.C. No. 45704.    S. No. 67-333 R.)
QUANTITY :    150   100-tablet btls. at Fort Worth, Tex. 
SHIPPED :    8-4-60, from Philadelphia, Pa.
LABEL IN PAST: (Btl.) "Becevit Therapeutic B-Complex with Vitamin C and 
Hesperidin Each Tablet Contains: %MDR Vitamin B-1 15 mg. 1500 Vita- 
min B-2 10 mg. 833 Vitamin B-6 5 mg. * * Vitamin C 250 mg. 750 Cal- 
cium Pantothenate 10 mg. * Hesperidin Purified 20 mg. * * Niacinamide 50 
mg. 500 *-The daily adult requirement has not been established. * *-The 
need for * * * in human nutrition * * * not established. Coral Laboratories 
Pharmaceuticals Dist. Co.   Fort Worth, Texas."
ACCOMPANYING LABELING: Detail cards reading in part "Becevite * * * 
Indications."
RESULTS OP INVESTIGATION : Investigation showed that the detail cards were 
printed locally on the order of the dealer, Coral Laboratories, Fort Worth, Tex.
LIBELED :    4-14-61, N. Dist. Tex.
CHARGE: 502(a)-while held for sale, the labeling (detail cards) contained 
false and misleading representations that the article was adequate and effective 
in hastening wound healing in pre- and post-surgical cases, in second- and 
third-degree burns, and in peptic ulcers; and the label statement "Each Tablet 
contains . . . Hesperidin Purified - 20 mg." was false and misleading since 
such ingredient would be of insignificant value for the effects claimed in the 
labeling of the article.
DISPOSITION : 5-25-61. Consent-claimed by Coral Laboratories and relabeled. 
Accompanying labeling destroyed.